Event Summary

The cancer-treatment landscape is changing rapidly from conventional chemo and hormonal therapy to targeted therapy, and is finally set to move towards cancer immunotherapy amid increasing competition.

Therapeutic cancer vaccines are a potential game changer, with established proof of concept. Learn about the developmental strategies of these therapies and the challenges pharmaceutical companies face in translating the promising approach into clinically feasible therapies.

We will also discuss a case study on the approved therapeutic cancer vaccine – focusing on launch history, clinical and commercial strategies and key learnings.

This webinar is the first in a series dedicated to assess the evolution of the cancer-treatment landscape and the potential of therapeutic cancer vaccines.

Panelists

Manish Chandna

Senior Vice President

Corporates and Consulting

Bhavna Mehta

Associate Vice President

Corporates and Consulting